• Skip to Content
  • Skip to Main Navigation
  • Skip to Information Links
  • Skip to Site Search
  • Skip to Footer
  • Skip to Accessibility Information
  • Home Page

This site is intended for healthcare professionals

Information Links

  • Menu
  • Sign in
  • Register
  • Subscribe
  • About us
  • FAQs
  • MIMS Adviser
  • GPonline
  • MIMS Learning
  • Medeconomics

Mims Home button

Menu

Main Navigation

  • News
  • Tables
  • Guidelines
  • Visual Guides
  • Clinics
  • Events
Click to search or browse MIMS
  • Drugs
  • Conditions
  • Articles
Browse drugs by section Browse drugs by manufacturer

Browse news and resources by disease area

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse all
Search Help

  • Trending trending icon
  • Antibiotic regimens
  • HRT comparison
  • Switching antidepressants
  • Asthma inhalers

Guidelines - Mental health

Quick-reference summaries of key national treatment guidance for mental health related conditions.

MIMS summaries

  • Current Medical Standards of Fitness to Drive (DVLA Guidance)

NICE technology appraisals

Decisions by the National Institute for Health and Care Excellence on NHS access to treatments for mental health disorders.

  • Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer's Disease (TA217)

  • Vortioxetine for Treating Major Depressive Episodes (TA367)

  • Aripiprazole for Treating Moderate to Severe Manic Episodes in Adolescents with Bipolar I Disorder (TA292)

  • Aripiprazole for the Treatment of Schizophrenia in People Aged 15 to 17 Years (TA213)

  • Insomnia: Zaleplon, Zolpidem and Zopiclone (NICE)

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

  • Cancer
  • Cardiology
  • Child Health
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Men's health
  • Mental health
  • Ophthalmology
  • Respiratory
  • Rheumatology
  • Smoking cessation
  • Women's health
Twitter  

  • Advertising and Sponsorship
  • Privacy Notice
  • Careers at Haymarket
  • Help
  • Terms and Conditions
  • Contact us
  • Editorial Complaint

Haymarket © Haymarket Media Group Ltd.